Journal article
Adverse Events to the Gadolinium-based Contrast Agent Gadoxetic Acid: Systematic Review and Meta-Analysis
Abstract
Background Gadoxetic acid is classified by the American College of Radiology as a group III gadolinium-based contrast agent (GBCA), which indicates that there are limited data regarding nephrogenic systemic fibrosis (NSF) risk, but there are few if any unconfounded cases of NSF. Purpose To perform a systematic review and meta-analysis of gadoxetic acid adverse events, including immediate hypersensitivity reactions, NSF, and intracranial …
Authors
Schieda N; van der Pol CB; Walker D; Tsampalieros AK; Maralani PJ; Woo S; Davenport MS
Journal
Radiology, Vol. 297, No. 3,
Publisher
Radiological Society of North America (RSNA)
Publication Date
December 2020
DOI
10.1148/radiol.2020200073
ISSN
0033-8419